{"organizations": [], "uuid": "4bf31728acdd84801f5ad01556af0c33118d3851", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://feeds.reuters.com/reuters/companyNews\r", "section_title": "Reuters: Company News", "url": "https://www.reuters.com/article/brief-mabvax-therapeutics-holdings-provi/brief-mabvax-therapeutics-holdings-provides-business-strategy-update-idUSASB0C104", "country": "US", "domain_rank": 408, "title": "BRIEF-Mabvax Therapeutics Holdings Provides Business Strategy Update", "performance_score": 0, "site": "reuters.com", "participants_count": 0, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-01-16T14:53:00.000+02:00", "replies_count": 0, "uuid": "4bf31728acdd84801f5ad01556af0c33118d3851"}, "author": "", "url": "https://www.reuters.com/article/brief-mabvax-therapeutics-holdings-provi/brief-mabvax-therapeutics-holdings-provides-business-strategy-update-idUSASB0C104", "ord_in_thread": 0, "title": "BRIEF-Mabvax Therapeutics Holdings Provides Business Strategy Update", "locations": [], "entities": {"persons": [], "locations": [], "organizations": [{"name": "brief-mabvax therapeutics holdings", "sentiment": "negative"}, {"name": "reuters", "sentiment": "none"}, {"name": "eikon", "sentiment": "none"}, {"name": "mabvax therapeutics holdings inc", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": " 54 PM / Updated 8 minutes ago BRIEF-Mabvax Therapeutics Holdings Provides Business Strategy Update Reuters Staff \nJan 16 (Reuters) - Mabvax Therapeutics Holdings Inc : \n* MABVAX THERAPEUTICS HOLDINGS, INC. PROVIDES BUSINESS STRATEGY UPDATE \n* MABVAX THERAPEUTICS - ON TRACK TO EXECUTE CORPORATE AND CLINICAL MILESTONES IN FIRST HALF OF 2018 \n* MABVAX - CURRENTLY IN “ADVANCED DISCUSSIONS” WITH A VARIETY OF INTERESTED PARTIES FOR POTENTIAL MULTIPLE DEAL PROPOSALS Source text for Eikon: Further company coverage:", "external_links": [], "published": "2018-01-16T14:53:00.000+02:00", "crawled": "2018-01-16T15:12:40.030+02:00", "highlightTitle": ""}